NASDAQ : PETS
PetMed Express, Inc. — Key statistics
Healthcare · Pharmaceutical Retailers · United States
Last price 1.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 24.84M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 25.05M |
| Enterprise Value | 12.39M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 21.05M |
| Shares Outstanding | 21.05M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +3.09% |
| Owned by Insiders (%) | 9.56% |
| Owned by Institutions (%) | 19.05% |
| Float | 13.26M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.68 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -198.86 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -78.56% |
| Return on Assets (ROA) | -20.05% |
| Return on Invested Capital (ROIC) | -302.82% |
| Return on Capital Employed (ROCE) | -120.19% |
| Weighted Average Cost of Capital (WACC) | 9.17% |
| Revenue Per Employee | $893,418 |
| Profits Per Employee | -$154,915 |
| Employee Count | 189 |
| Asset Turnover | 1.95 |
| Inventory Turnover | 9.07 |
Taxes
| Measure | Value |
|---|
| Income Tax | -69,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -54.05% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 2.11 |
| Relative Strength Index (RSI) | 33.89 |
| Average Volume (20 Days) | 105,636 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 896,242 |
| Short Previous Month | 691,516 |
| Short % of Shares Out | 4.26% |
| Short % of Float | 6.76% |
| Short Ratio (days to cover) | 6.25 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 168.86M |
| Gross Profit | 47.15M |
| Operating Income | -27.84M |
| Pretax Income | -29.35M |
| Net Income | -29.28M |
| EBITDA | -18.59M |
| EBIT | -27.84M |
| Loss Per Share | -$1.38 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.08M |
| Total Debt | 414,000 |
| Net Cash | 12.67M |
| Net Cash Per Share | $0.60 |
| Equity (Book Value) | 22.99M |
| Book Value Per Share | 1.09 |
| Working Capital | -12.99M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -23.81M |
| Capital Expenditures | -3.96M |
| Depreciation & Amortization | 9.25M |
| Net Borrowing | n/a |
| Free Cash Flow | -27.77M |
| FCF Per Share | -$1.32 |
Margins
| Measure | Value |
|---|
| Gross Margin | 27.92% |
| Operating Margin | -16.49% |
| Pretax Margin | -17.38% |
| Profit Margin | -17.34% |
| EBITDA Margin | -11.01% |
| EBIT Margin | -16.49% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | -116.31% |
| FCF Yield | -110.87% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | -4.31% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |